New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

To tackle the ongoing high burden of hepatitis C virus (HCV) infections among people who inject drugs (PWID), WHO has set a specific incidence target among PWID of no more than two new infections per ...

China Objective This study aimed to investigate the therapeutic potential of monoclonal antibody (mAb) against HBV as a novel treatment approach to chronic hepatitis B (CHB) in mouse models. Methods ...

DAAs use in HIV–HCV-coinfected patients may increase the proportion of hepatitis C individuals harboring non-HCV genotype 1 or drug-resistant HCV variants. Over time a reservoir of HCV genotype ...

Blood testing for HIV antigen and antibodies was negative; a PCR assay for HIV RNA was also negative. Blood tests for hepatitis A virus IgM, hepatitis B virus core IgM, hepatitis B virus surface ...

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

Anti-nuclear antibodies and anti-smooth muscle actin antibodies were negative. Tests for hepatitis B, hepatitis C virus, and HIV were also negative. The necessity of liver biopsy remains controversial ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths increased from 1.1 million in 2019 to 1.3 million in 2022, rates now ...

A thyroglobulin antibody (TgAb) test looks for certain antibodies that attack the thyroid. The presence of TbAb in high levels may indicate that someone has an autoimmune condition. To conduct a ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

Ali and colleagues developed recommendations based on patient HBV infection status — hepatitis B surface antigen positive vs. HBsAg negative/anti-HB core antibody (HBc)-positive — and risk for ...